ANNEXON, INC. Other Comprehensive Income (Loss), Net of Tax
ANNEXON, INC. (ANNX) reported Other Comprehensive Income (Loss), Net of Tax of -$1.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-12
- ANNEXON, INC. other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was -$1.00K.
- ANNEXON, INC. other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was -$52.00K.
- ANNEXON, INC. other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was $17.00K, a 89.76% decline year-over-year.
- ANNEXON, INC. other comprehensive income (loss), net of tax for the quarter ending 2025-06-30 was -$2.00K, a 115.38% decline year-over-year.
- ANNEXON, INC. other comprehensive income (loss), net of tax for fiscal 2025 was -$39.00K, a 162.90% decline from fiscal 2024.
- ANNEXON, INC. other comprehensive income (loss), net of tax for fiscal 2024 was $62.00K, a 80.63% decline from fiscal 2023.
- ANNEXON, INC. other comprehensive income (loss), net of tax for fiscal 2023 was $320.00K.
- ANNEXON, INC. other comprehensive income (loss), net of tax for fiscal 2022 was -$192.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.00K 10-Q · filed 2026-08-12 | -$53.00K derived: sum of 2 quarters · filed 2026-08-12 | ||
| 2026-03-31 | -$52.00K 10-Q · filed 2026-08-12 | |||
| 2025-12-31 | -$39.00K 10-K · filed 2026-03-30 | |||
| 2025-09-30 | $17.00K 10-Q · filed 2025-11-10 | $15.00K derived: sum of 2 quarters · filed 2026-08-12 | -$86.00K derived: sum of 3 quarters · filed 2026-08-12 | |
| 2025-06-30 | -$2.00K 10-Q · filed 2026-08-12 | -$103.00K derived: sum of 2 quarters · filed 2026-08-12 | ||
| 2025-03-31 | -$101.00K 10-Q · filed 2026-08-12 | |||
| 2024-12-31 | $62.00K 10-K · filed 2026-03-30 | |||
| 2024-09-30 | $166.00K 10-Q · filed 2025-11-10 | $179.00K derived: sum of 2 quarters · filed 2025-11-10 | $129.00K derived: sum of 3 quarters · filed 2025-11-10 | |
| 2024-06-30 | $13.00K 10-Q · filed 2025-11-10 | -$37.00K derived: sum of 2 quarters · filed 2025-11-10 | ||
| 2024-03-31 | -$50.00K 10-Q · filed 2025-11-10 | |||
| 2023-12-31 | $320.00K 10-K · filed 2025-03-03 | |||
| 2023-09-30 | $48.00K 10-Q · filed 2024-11-14 | $94.00K derived: sum of 2 quarters · filed 2024-11-14 | $249.00K derived: sum of 3 quarters · filed 2024-11-14 | |
| 2023-06-30 | $46.00K 10-Q · filed 2024-11-14 | $201.00K derived: sum of 2 quarters · filed 2024-11-14 | ||
| 2023-03-31 | $155.00K 10-Q · filed 2024-11-14 | |||
| 2022-12-31 | -$192.00K 10-K · filed 2024-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |